公司資料
Aldeyra Therapeutics, Inc. 股價、新聞與催化劑
- 股票代碼:
- ALDX
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
1.56 USD (0.00%)
收盤價
最後更新: 2026年8月17日
98.9M USD
市值
股價為何變動
As of Aug 17, 2026, ALDX was little changed and closed at $1.56. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Aldeyra Therapeutics is a biotechnology company focused on inflammation, ophthalmology, and immune-mediated disease. Its story is built around therapies for conditions where inflammation plays a major role.
所在地與產業分類
Aldeyra is headquartered in the United States and listed on NASDAQ. It sits in specialty immunology and ophthalmology biotechnology.
商業模式特徵
The company depends on clinical data, regulatory progress, and the ability to develop a focused pipeline in challenging inflammatory diseases. Investors usually watch efficacy, safety, and approval milestones.
生技產業定位
Aldeyra occupies a niche inflammation-and-eye-disease position within biotech. The stock is catalyst-sensitive because a narrow number of data events can meaningfully shift the story.
未來催化劑
- Aldeyra’s catalysts are reproxalap and the dry-eye / ophthalmology regulatory path, where the next step can materially move the stock. The company is still very event-driven.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。